OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ferroptosis mechanisms and its novel potential therapeutic targets for DLBCL
Wenxia Bian, Haoran Li, Yuhan Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116386-116386
Open Access | Times Cited: 9
Wenxia Bian, Haoran Li, Yuhan Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116386-116386
Open Access | Times Cited: 9
Showing 9 citing articles:
Bi-targeting of thioredoxin 1 and telomerase by thiotert promotes cell death of myelodysplastic syndromes and lymphoma
Qiangan Jing, Yunyi Wu, Yanchun Li, et al.
Biology Direct (2025) Vol. 20, Iss. 1
Open Access
Qiangan Jing, Yunyi Wu, Yanchun Li, et al.
Biology Direct (2025) Vol. 20, Iss. 1
Open Access
Ferroptosis in thyroid cancer: mechanisms, current status, and treatment
Wenzhi Tian, Xi Su, Chenchen Hu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Wenzhi Tian, Xi Su, Chenchen Hu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Ferroptosis: emerging roles in lung cancer and potential implications in biological compounds
Qiuran Liang, Yuehui Wang, Yili Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Qiuran Liang, Yuehui Wang, Yili Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
The multifaceted perspectives on the regulation of lncRNAs in hepatocellular carcinoma ferroptosis: from bench-to-bedside
Xin Jin, C. Huang, Yue Tian
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Xin Jin, C. Huang, Yue Tian
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Natural products as anticancer agents and enhancing their efficacy by a mechanism-based precision approach
Stephen Safe
(2024), pp. 408-427
Open Access | Times Cited: 1
Stephen Safe
(2024), pp. 408-427
Open Access | Times Cited: 1
Identification of ferroptosis-related genes associated with diffuse large B-cell lymphoma via bioinformatics and machine learning approaches
Z. H. Jia, Jiayi Zhang, Zijia Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 137117-137117
Closed Access | Times Cited: 1
Z. H. Jia, Jiayi Zhang, Zijia Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 137117-137117
Closed Access | Times Cited: 1
In Silico Discovery of a Novel PI3Kδ Inhibitor Incorporating 3,5,7-Trihydroxychroman-4-one Targeting Diffuse Large B-Cell Lymphoma
Wenqing Jia, Jingdian Liu, Xian‐Chao Cheng, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11250-11250
Open Access
Wenqing Jia, Jingdian Liu, Xian‐Chao Cheng, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11250-11250
Open Access
Tumor Biology Hides Novel Therapeutic Approaches to Diffuse Large B-Cell Lymphoma: A Narrative Review
Romana Masnikosa, Zorica Cvetković, David Pirić
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11384-11384
Open Access
Romana Masnikosa, Zorica Cvetković, David Pirić
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11384-11384
Open Access
Rituximab induces ferroptosis and RSL3 overcomes rituximab resistance in diffuse large B-cell lymphoma cells
Haiyi Wu, Linqing Zou, Ying Jin, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110188-110188
Closed Access
Haiyi Wu, Linqing Zou, Ying Jin, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110188-110188
Closed Access
